Health 2030 Genome Center

What Health 2030 Genome Center does

Health 2030 Genome Center is a Swiss non-profit genomic sequencing and data interpretation hub, established in 2017 and operating from Campus Biotech in Geneva. It was founded as a joint initiative by EPFL and the universities and university hospitals of Bern, Geneva, and Lausanne (UNIBE, Inselspital, UNIL, CHUV, UNIGE, HUG) to serve as a national platform for clinical-grade genomic medicine and large-scale research projects.

The center runs two integrated platforms: a DNA Sequencing Platform built on Illumina instruments with PCR-free library prep for whole genome sequencing, Twist/IDT exome capture for whole exome sequencing, and Illumina TruSeq Stranded mRNA-seq for RNA sequencing, plus a Data Analytics and Interpretation Platform providing validated, hardware-accelerated pipelines and ISO 15189-accredited integration of the Congenica AI-powered variant interpretation tool. Service scope extends to low-coverage WGS with imputation, viral pathogen WGS (including SARS-CoV-2 surveillance work for the Federal Office of Public Health), microbiome WGS, tumor profiling assays, and secure data governance with encrypted transfer and tiered storage. A fast-turnaround clinical service delivers WGS/WES/RNA-seq data from sample in under 7 days.

The business model is professional-services revenue from multi-year Customer Service Agreements with hospitals, university research groups, and government programs, conducted under ISO 15189:2013 accreditation (extended in April 2025 to a C-type flexible scope). The center bills on quote-based pricing recorded in CSA appendices, with no patient-facing channel, no retail or SMB distribution, and operations confined to Switzerland. The center is currently pursuing ISO 27001 certification and is a member of the Swiss Multi-Omics Center (SMOC) and the Swiss Personalized Health Network (SPHN).

Name

Health 2030 Genome Center

Legal name

Health 2030 Genome Center (legally represented by Fondation Campus Biotech Geneva)

Website

https://health2030genome.ch

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Swiss non-profit clinical genomics hub in Geneva, founded 2017 by EPFL and the universities and university hospitals of Bern, Geneva, and Lausanne; delivers ISO 15189-accredited WGS, WES, RNA-seq, and Congenica AI-powered variant interpretation to hospitals and research institutions in Switzerland.

Ownership category

akta.pro rank

Product category

Genomic Sequencing Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

akta.pro secondary industries

Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD), Transcriptomics & Gene Expression Profiling Services (HLAGANAE), Genomic Profiling & Sequencing-Based Precision Medicine (HLAAANAA)

Keywords

• Clinical genomic sequencing
• Whole genome sequencing
• RNA sequencing services
• Variant interpretation services
• Clinical diagnostics genomics

Headquarters

HQ city

Geneva

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Others

Revenue model

1. Genomic Sequencing Services: The Health 2030 Genome Center provides ISO 15189 accredited DNA and RNA sequencing services to hospitals, clinics, research institutions, and research organizations. Services include Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), and RNA sequencing. The center is a not-for-profit institution with a service vocation focused on improving healthcare based on advances in genomics research.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

Health 2030 Genome Center is a Swiss non-profit genomic sequencing facility that delivers ISO 15189-accredited clinical-grade DNA and RNA sequencing and bioinformatics interpretation services to hospitals, clinics, and research institutions. Its DNA Sequencing Platform performs whole-genome, whole-exome, RNA-seq, viral pathogen, microbiome, and tumor profiling sequencing, while its Data Analytics and Interpretation Platform applies automated pipelines and the Congenica AI variant interpretation engine to produce clinically actionable results. All projects are executed under Customer Service Agreements, with optional fast turnaround in under 7 days and secure data governance.

Product overview

The Health 2030 Genome Center is a non-profit institution offering a comprehensive genomic services portfolio centered around two core platforms: the DNA Sequencing Platform (DSP) and the Data Analytics and Interpretation Platform (DAIP). The DSP provides clinical-grade nucleic acid sequencing including Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), and RNA Sequencing (RNA-seq), with optional fast turnaround times under 7 days. The DAIP delivers data processing, genome variant calling, clinical annotation, and RNA expression profiling, with an ISO 15189 accredited integration of the Congenica AI-powered variant interpretation platform. The center also offers specialized services including low-coverage WGS with variant imputation, viral pathogen WGS (including SARS-CoV-2), microbiome WGS, and a two-on-one tumor profiling assay combining RNA-fusion detection with full transcriptome profiling. All services are delivered with secure data governance including encrypted transfer and configurable storage options.

Differentiator

Problem solved

Functional benefit

Products and services

• Whole Genome Sequencing (WGS) Clinical-grade human whole genome sequencing service based on Illumina PCR-free library preparation and Illumina sequencing, delivering FASTQ files and delivery reports with quality metrics to hospitals, clinics, and research institutions.
• Whole Exome Sequencing (WES) Clinical-grade human whole exome sequencing service based on Twist/IDT exome capture library reagents and Illumina sequencing, with QC performed by fluorescence-based quantification and sample integrity checks.
• RNA Sequencing (RNA-seq) Clinical-grade human full transcriptome RNA-seq service based on Illumina TruSeq Stranded mRNA-seq library reagents and Illumina sequencing.
• DNA Sequencing Platform (DSP) Operational sequencing platform at Campus Biotech Geneva supporting large-scale genetics and genomics research and clinical-grade diagnostic nucleic acid sequencing through automated workflows for sample processing, library preparation, and high-throughput DNA sequencing.
• Data Analytics and Interpretation Platform (DAIP) Data analytics service delivering automated and hardware-accelerated pipelines optimized for large-scale projects while producing clinical-grade outputs, supporting variant calling, clinical annotation, and RNA expression profiling for clinical and research customers.
• Fast Turnaround Time Sequencing Service Premium fast turnaround clinical-grade sequencing service for WGS, WES, and RNA-seq that delivers data generation from sample delivery in less than 7 days, targeting time-critical clinical diagnostics.
• Low-Coverage WGS with Variant Imputation Low-coverage whole genome sequencing combined with variant imputation service designed for cost-effective population genomics research.
• Viral Pathogen WGS Whole genome sequencing services for viral pathogens, including WGS-based respiratory virus detection and assembly, and SARS-CoV-2 sequencing and consensus sequence assembly.
• Microbiome WGS Whole genome sequencing service for microbiome analysis, supporting metagenomics studies.
• Sequencing of User-Prepared Libraries Sequencing service accepting customer-prepared libraries, providing the high-throughput Illumina sequencing run while the customer retains upstream library preparation.
• Congenica AI-Powered Variant Interpretation AI-powered genome interpretation service using the Congenica platform to filter and interpret genetic variants for clinical decision support, operating as an ISO 15189-accredited integration within the Health 2030 workflow.
• Two-on-One Tumor Profiling Assay Tumor profiling assay combining RNA-fusion transcript detection and full transcriptome profiling from a single sample, supporting precision oncology applications.
• Genomic Data Processing and Governance Services Secure data lifecycle governance services for sensitive human genome data, including 6-month standard storage, extended storage options up to 5 years with tiered pricing, and per-sample encrypted data transfer.

Quantifiable outcome

• Hundreds of human genomes can be sequenced per week
• +1 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature4 records

Partnerships

13 partnerships are on record, tiered strategic, core and major.

• GCIR Unige (Geneva Center for Integrative Genomics)strategicStrategic or Co-development Partner · 17 September 2024Collaboration announced on developing multiomic tools for clinical decision-support and improved patient care as part of PHRT and Swiss Multiomic Center initiatives.
• CongenicacoreTechnology or Integration · 1 January 2023Congenica provides the AI-powered genome interpretation platform used by the Genome Center for variant filtering and clinical decision support. The platform is ISO 15189 accredited and certified as a medical device, enabling fast and robust interpretation of human genomes.
• Federal Office of Public Health (FOPH)majorOthers · 1 January 2021The Swiss National SARS-CoV-2 Genomic Surveillance Program was introduced by FOPH in May 2021. The Genome Center performs most of the SARS-CoV-2 sequencing under this program, processing approximately 500 samples per week.
• Swiss Multi-Omics Center (SMOC)coreStrategic or Co-development PartnerThe Health 2030 Genome Center is part of the Swiss Multi-Omics Center (SMOC). This center combines expertise in genomics, transcriptomics, proteomics, and metabolomics for integrated multi-omic analysis of clinical specimens. SMOC is hosted at ETH Zurich (http://smoc.ethz.ch).
• EPFL (École Polytechnique Fédérale de Lausanne)coreStrategic or Co-development PartnerEPFL is one of the founding partners of the Health 2030 initiative and Genome Center. Contributes expertise in life sciences and computational biology.
• UNIGE (University of Geneva)coreStrategic or Co-development PartnerUniversity of Geneva is a founding partner of the Health 2030 Genome Center, contributing research expertise and hosting the Center for Emerging Viral Diseases.
• UNIL (University of Lausanne)coreStrategic or Co-development PartnerUniversity of Lausanne is a founding partner providing genomic research expertise through the Center for Integrative Genomics.
• UNIBE (University of Bern)coreStrategic or Co-development PartnerUniversity of Bern is a founding partner contributing through Inselspital and research expertise.
• HUG (Geneva University Hospitals)coreStrategic or Co-development PartnerHUG is a founding partner and hosts the Center for Emerging Viral Diseases. Collaborates on SARS-CoV-2 genomic surveillance and clinical genomics projects.
• CHUV (Lausanne University Hospital)coreStrategic or Co-development PartnerCHUV is a founding partner contributing through the Precision Medicine Unit and clinical research expertise.
• Inselspital (Bern University Hospital)coreStrategic or Co-development PartnerInselspital is a founding partner contributing clinical expertise and research capabilities.
• Swiss Personalized Health Network (SPHN)majorStrategic or Co-development PartnerSPHN is the Swiss national initiative for personalized health. Data transfers comply with SPHN Information Security Policy. The Genome Center participates in national genomic initiatives coordinated through SPHN.
• Swiss Institute of Bioinformatics (SIB)majorStrategic or Co-development PartnerSIB developed the Swiss Pathogen Surveillance Platform (SPSP) used for sharing viral sequences. Collaborates on pathogen genomics and bioinformatics infrastructure.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• CeGaT: Germany-based clinical genomics service provider offering WGS, WES, RNA-seq, and panel sequencing with CAP/CLIA and ISO 15189 accreditation for hospitals and research institutions. Closely comparable to Health 2030 as a European accredited clinical sequencing lab serving hospital customers.
• Blueprint Genetics: Clinical genetic testing and genomics services provider (now part of Amgen) offering WES, WGS, and panel testing for hereditary disease and oncology. Highly comparable as an accredited clinical sequencing service targeting hospital systems.
• Centogene: Germany-headquartered clinical genomics company focused on rare disease and hereditary disease diagnostics, offering WES/WGS and biomarker services globally. Directly comparable as a clinical-grade genomic sequencing and interpretation provider serving hospital and clinical customers.
• Macrogen: South Korea-based genomic sequencing and bioinformatics service provider offering WGS, WES, RNA-seq and clinical sequencing services to research and clinical customers globally. Comparable as an end-to-end sequencing and analytics service provider, though at larger scale and with broader geographic reach.
• PreventionGenetics: US clinical genetic testing laboratory (part of Exact Sciences) offering WES, WGS, and a broad menu of inherited disease tests with CLIA/CAP accreditation. Comparable as a hospital-facing accredited clinical sequencing lab.

Broad incumbents

• GeneDx: US-based clinical genomics company focused on rare disease, hereditary cancer, and rare pediatric disease testing using WES/WGS at significant scale. Comparable as a clinical-grade genomic sequencing and interpretation provider, though operating at substantially larger scale and primarily US-focused.
• BGI Genomics: China-based global genomics services provider operating its own DNBSEQ sequencing platform with high-throughput WGS and clinical sequencing capacity. Comparable as a large-scale clinical and population genomics service provider, though vertically integrated on proprietary technology.
• Eurofins Genomics: Global genomics services arm of Eurofins Scientific offering sequencing, genotyping, and bioinformatics services to research and clinical customers. Comparable in offering sequencing-as-a-service with integrated data analytics, but operating across a much broader customer base.

Others

• Congenica: UK-based AI-powered clinical genomic variant interpretation platform that Health 2030 has integrated under its ISO 15189 scope. Comparable as an enabling technology partner whose platform is core to the center's clinical interpretation offering.
• Illumina: Dominant sequencing platform vendor whose instruments, reagents, and library prep kits underpin Health 2030's core WGS/WES/RNA-seq workflows. Comparable as an enabling technology and infrastructure provider rather than a direct competitor, but strategically critical.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/swissgenomics
• LinkedInlinkedin.com/company/health2030-genomecenter

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Health 2030 Genome Center